Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHipgnosis Song. Regulatory News (SONG)

Share Price Information for Hipgnosis Song. (SONG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 103.40
Bid: 103.20
Ask: 103.60
Change: -0.20 (-0.19%)
Spread: 0.40 (0.388%)
Open: 103.40
High: 103.60
Low: 103.40
Prev. Close: 103.60
SONG Live PriceLast checked at -
Hipgnosis Songs is an Investment Trust

To provide shareholders with an attractive and growing level of income, together with the potential for capital growth, from investment in songs and associated musical intellectual property rights.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Placing

27 Aug 2019 18:13

RNS Number : 3254K
Hipgnosis Songs Fund Limited
27 August 2019
 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY MEMBER STATE OF THE EEA (OTHER THAN THE UNITED KINGDOM) OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION, DISTRIBUTION OR RELEASE OF THIS ANNOUNCEMENT WOULD BE UNLAWFUL. PLEASE SEE THE SECTION ENTITLED "IMPORTANT NOTE" TOWARDS THE END OF THIS ANNOUNCEMENT.

27 August 2019

Hipgnosis Songs Fund Limited ("Hipgnosis" or the "Company")

Result of Placing

Further to its announcement earlier today, Hipgnosis and its Investment Adviser, The Family (Music) Limited, are pleased to announce that the Company has successfully raised approximately £51.1 million at a price of 105.5 pence per share, principally from existing shareholders, and accordingly the Placing has now closed.

The new Ordinary Shares to be issued under the Placing will represent 12.4% of the Company's enlarged issued Ordinary Share capital.

Application has been made in respect of 48,429,541 Ordinary Shares to be admitted to trading on the Specialist Fund Segment of the Main Market of the London Stock Exchange plc ("Admission"). It is expected that Admission will become effective and that dealings in the new Ordinary Shares will commence at 8.00 a.m. (London time) on 29 August 2019.

Total Voting Rights

Following Admission, the Company will have 389,356,341 Ordinary Shares in issue. The Company does not hold any Ordinary Shares in Treasury. Therefore, the total number of voting rights of the Company will be 389,356,341 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Merck Mercuriadis, Founder of The Family (Music) Limited and Hipgnosis Songs Fund Limited, said:

"We are delighted to continue giving our shareholders exposure to music royalties via new acquisitions of some of the most iconic songs of all time. I'm very grateful for the constant enthusiasm and support that the finest institutional investors in the world have given us to establish songs as an asset class. This is not only great for the investors but the songwriting and artistic community as well."

Expected timetable

Trade date

27 August 2019

Admission

08.00 a.m. on 29 August 2019

Crediting of CREST stock accounts in respect of the new Ordinary Shares

29 August 2019

 

Unless otherwise defined, capitalised terms in this announcement shall have the meaning given to them in the announcement made on 27 August 2019 at 07:00.

For further information, please contact: The Family (Music) Limited

Merck Mercuriadis

 

Tel: +44 (0)1481 742742

N+1 Singer

James Maxwell / James Moat (Corporate Finance)

Alan Geeves / James Waterlow / Sam Greatrex (Sales)

 

Tel: +44 (0)20 7496 3000

The Outside Organisation

Alan Edwards / Nick Caley

Tel: +44 (0)7711 081 843

 

NOTES TO EDITORS

About Hipgnosis Songs Fund Limited

(www.hipgnosissongs.com)

Hipgnosis, which was founded by Merck Mercuriadis, is a Guernsey registered investment company established to offer investors a pure-play exposure to songs and associated musical intellectual property rights. In its Initial Public Offering on the Specialist Fund Segment of the London Stock Exchange's main market on 11 July 2018, the Company raised approximately £200m gross equity capital. In its Subsequent Placing under its Placing Programme on 12 April 2019, the Company raised approximately £140m of further equity capital.

About The Family (Music) Limited

The Company's Investment Adviser is The Family (Music) Limited, which was founded by Merck Mercuriadis, former manager of globally successful recording artists, such as Elton John, Guns N' Roses, Morrissey, Iron Maiden and Beyoncé, and hit songwriters such as Diane Warren, Justin Tranter and The-Dream, and former CEO of The Sanctuary Group plc. The Investment Adviser has assembled an Advisory Board of highly successful music industry experts which include award winning members of the artist, songwriter, publishing, legal, financial, recorded music and music management communities, all with in-depth knowledge of music publishing. Members of The Family (Music) Limited Advisory Board include Nile Rodgers, The-Dream, Giorgio Tuinfort, Starrah, Nick Jarjour, David Stewart, Bill Leibowitz, Ian Montone, and Jason Flom.

Disclaimers

Members of the public are not eligible to take part in the Placing. This announcement and the terms and conditions referred to herein are directed in the United Kingdom only at persons selected by the N+1 Singer who are "investment professionals" falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "FPO") or "high net worth companies, unincorporated associations etc" falling within Article 49(2) of the FPO, or persons to whom it may otherwise be lawfully communicated (all such persons together being referred to as "Relevant Persons"). This announcement and the terms and conditions referred to herein must not be acted on or relied on in the United Kingdom by persons who are not Relevant Persons. Any investment or investment activity to which this announcement relates is available only to, and will be engaged in only with, persons in the United Kingdom who are Relevant Persons.

The new Ordinary Shares that are the subject of the Placing are not being offered or sold to any person in the European Union, other than to "qualified investors" as defined in Article 2.1 of Directive 2003/71/EC, which includes legal entitles which are regulated by the Financial Conduct Authority or entities which are not so regulated whose corporate purpose is solely to invest in securities.

In the United Kingdom, this announcement is being directed solely at persons in circumstances in which section 21(1) of the Financial Services and Markets Act 2000 (as amended) does not apply. This announcement does not constitute or form part of, and should not be construed as, any offer or invitation or inducement for sale, transfer or subscription of, or any solicitation of any offer or invitation to buy or subscribe for or to underwrite, any share in the Company or to engage in investment activity (as defined by the Financial Services and Markets Act 2000) in any jurisdiction nor shall it, or any part of it, or the fact of its distribution form the basis of, or be relied on in connection with, any contract or investment decision whatsoever, in any jurisdiction. This announcement does not constitute a recommendation regarding any securities.

The information in this announcement is for information purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy or completeness. The material set forth herein is not intended, and should not be construed, as an offer of securities for sale or subscription in the United States or any other jurisdiction. 

This announcement is not for publication or distribution, directly or indirectly, in or into the United States (including its territories and possessions, any state of the United States and the District of Columbia), Australia, Canada, South Africa or Japan. The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

The Company will not be registered under the US Investment Company Act of 1940, as amended. In addition, the Shares referred to herein have not been and will not be registered under the US Securities Act of 1933 (the "Securities Act") or under the securities laws of any state of the United States and may not be offered or sold in the United States or to or for the account or benefit of US persons absent registration or pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable State securities laws. The offer and sale of Shares referred to herein has not been and will not be registered under the Securities Act or under the applicable securities laws of any state, province or territory of Australia, Canada, South Africa or Japan. Subject to certain exceptions, the Shares referred to herein may not be offered or sold in Australia, Canada, South Africa or Japan or to, or for the account or benefit of, any national, resident or citizen of Australia, Canada, South Africa or Japan. There will be no offer of the Shares in the United States, Australia, Canada, South Africa or Japan.

N+1 Singer is authorised and regulated in the United Kingdom by the Financial Conduct Authority, and is acting exclusively for the Company and no-one else in connection with the Placing Programme and Admission. They will not regard any other person as their respective clients in relation to the Placing Programme and Admission and will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients, nor for providing advice in relation to the Placing Programme and Admission, the contents of this announcement or any transaction, arrangement or other matter referred to herein.

None of the Company, the Investment Adviser or N+1 Singer or any of their respective affiliates accepts any responsibility or liability whatsoever for/or makes any representation or warranty, express or implied, as to this announcement, including the truth, accuracy or completeness of the information in this announcement (or whether any information has been omitted from the announcement) or any other information relating to the Company whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of the announcement or its contents or otherwise arising in connection therewith. The Company, the Investment Adviser and N+1 Singer and their respective affiliates accordingly disclaim all and any liability whether arising in tort, contract or otherwise which they might otherwise have in respect of this announcement or its contents or otherwise arising in connection therewith.

This announcement may include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements involve known and unknown risks and uncertainties, many of which are beyond the Company's control and all of which are based on the Company's board of directors' current beliefs and expectations about future events. These forward-looking statements may be identified by the use of forward- looking terminology, including the terms "believes", "estimates", "plans", "projects", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward-looking statements include all matters that are not historical facts. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements reflect the Company's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to the Company's business, the results of operations, financial condition prospects, growth and dividend policy of the Company and the industry in which it operates. Forward-looking statements speak only as of the date they are made and cannot be relied upon as a guide to future performance. These forward-looking statements and other statements contained in this announcement regarding matters that are not historical facts involve predictions. No assurance can be given that such future results will be achieved; actual events or results may differ materially as a result of risks and uncertainties facing the Company. Such risks and uncertainties could cause actual results to vary materially from the future results indicated, expressed or implied in such forward-looking statements. Forward looking statements speak only as of the date of this announcement.

The Company has a limited trading history. Potential investors should be aware that any investment in the Company is speculative, involves a high degree of risk, and could result in the loss of all or substantially all of their investment. Results can be positively or negatively affected by market conditions beyond the control of the Company or any other person.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROIPGUBURUPBGMM
Date   Source Headline
26th Apr 20247:00 amRNSForm 8.3 - Hipgnosis Songs Fund Limited
25th Apr 20242:56 pmRNSForm 8.3 - Hipgnosis Songs Fund Limited
25th Apr 20242:22 pmEQSForm 8.3 - The Vanguard Group, Inc.: Hipgnosis Songs Fund Ltd
25th Apr 20242:12 pmGNWForm 8.3 - Hipgnosis Songs Fund Limited
25th Apr 202412:42 pmRNSForm 8.5 (EPT/NON-RI) Hipgnosis Songs Fund Limited
25th Apr 202412:32 pmRNSForm 8.3 - Hipgnosis Songs Fund Limited
25th Apr 202412:30 pmRNSForm 8.5 (EPT/NON-RI) Hipgnosis Songs Fund Limited
25th Apr 202411:55 amRNSForm 8 (DD) - Hipgnosis Songs Fund Limited
25th Apr 202411:54 amRNSForm 8.3 - Hipgnosis Songs Fund Limited
25th Apr 202411:50 amRNSForm 8 (OPD) Hipgnosis Songs Fund Limited
25th Apr 202411:08 amRNSForm 8.5 (EPT/RI)-Hipgnosis Songs Fund Limited
25th Apr 20249:03 amRNSResponse to Announcement Regarding Hipgnosis
25th Apr 20247:00 amRNSRule 2.10 Disclosure - CCLA
25th Apr 20247:00 amRNSForm 8.3 - Hipgnosis Songs Fund Limited
24th Apr 20246:29 pmRNSRecommended increased cash offer for Hipgnosis
24th Apr 20243:24 pmRNSForm 8.5 (EPT/RI)-Hipgnosis Songs Fund Ltd Amend
24th Apr 20243:13 pmRNSForm 8.5 (EPT/RI) - Hipgnosis Songs Fund Ltd Amend
24th Apr 20243:05 pmRNSForm 8.3 - Hipgnosis Songs Fund Limited
24th Apr 20243:04 pmRNSForm 8.5 (EPT/RI)-Hipgnosis Songs Fund Ltd Amend
24th Apr 20242:49 pmGNWForm 8.3 - Hipgnosis Songs Fund Ltd
24th Apr 20242:08 pmRNSForm 8.3 - Hipgnosis Songs Fund Limited
24th Apr 20241:56 pmEQSForm 8.3 - The Vanguard Group, Inc.: Hipgnosis Songs Fund Limited
24th Apr 202412:21 pmRNSForm 8.3 - Hipgnosis Songs Fund Limited
24th Apr 202412:16 pmRNSForm 8.5 (EPT/NON-RI) Hipgnosis Songs Fund Limited
24th Apr 202411:20 amRNSForm 8.5 (EPT/RI)-Hipgnosis Songs Fund Limited
24th Apr 202410:00 amRNSForm 8.3 - Hipgnosis Songs Fund Limited
24th Apr 20249:45 amRNSForm 8.5 (EPT/RI)
24th Apr 20247:00 amRNSForm 8.3 - Hipgnosis Songs Fund Limited
23rd Apr 20243:37 pmRNSForm 8.3 - Hipgnosis Songs Fund Limited
23rd Apr 20243:25 pmRNSForm 8.3 - Hipgnosis Songs Fund Limited
23rd Apr 20243:23 pmRNSForm 8.3 - Hipgnosis Songs Fund Limited
23rd Apr 20242:25 pmRNSForm 8.3 - Hipgnosis Songs Fund Limited
23rd Apr 20241:50 pmGNWForm 8.3 - Hipgnosis Songs Fund Limited
23rd Apr 202412:08 pmRNSForm 8.5 (EPT/RI)
23rd Apr 202412:00 pmRNSForm 8.3 - Hipgnosis Songs Fund Limited
23rd Apr 202411:43 amRNSForm 8.5 (EPT/NON-RI)-Hipgnosis Songs Fund Limited
23rd Apr 202411:35 amRNSForm 8.5 (EPT/RI)-Hipgnosis Songs Fund Limited
23rd Apr 202411:18 amRNSForm 8.5 (EPT/NON-RI) Hipgnosis Songs Fund Limited
23rd Apr 202411:15 amRNSForm 8.3 - Hipgnosis Songs Fund Limited
23rd Apr 20247:00 amRNSRule 2.10 Disclosure - JOHCM
23rd Apr 20247:00 amRNSForm 8.3 - Hipgnosis Songs Fund Limited
23rd Apr 20247:00 amRNSForm 8.3 - Hipgnosis Songs Fund Limited
23rd Apr 20247:00 amRNSForm 8.3 - Hipgnosis Songs Fund Limited
22nd Apr 20246:20 pmRNSForm 8.3 - Hipgnosis Songs Fund Ltd - Replacement
22nd Apr 20245:41 pmRNSForm8.5(EPT/RI)-Hipgnosis Songs Fund Ltd Amendment
22nd Apr 20244:34 pmRNSForm 8.3 - Hipgnosis Songs Fund Ltd - Replacement
22nd Apr 20243:39 pmRNSForm 8.3 - Hipgnosis Songs Fund Limited
22nd Apr 20243:25 pmRNSForm 8.3 - Hipgnosis Songs Fund Limited
22nd Apr 20243:25 pmRNSForm 8.3 - Hipgnosis Songs Fund Limited
22nd Apr 20242:50 pmRNSForm 8.3 - Hipgnosis Songs Fund Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.